were analyzed regarding clinical details, investigations and treatment outcomes.
INtRoduCtIoN
Gestational trophoblastic disease (GTD) represents a spectrum of histologically distinct pathologies including molar pregnancy, invasive mole, placental site trophoblastic tumour and choriocarcinoma. Invasive mole, placental site trophoblastic tumour and choriocarcinoma grouped as gestational trophoblastic tumours (GTT) has been referred to as "God's first cancer and man's first cure". 1 Prior to 1956, GTT treatment usually involved surgical removal of the primary or metastatic lesions or perhaps radiotherapy. The treatment failure occurred in metastatic disease with fatal outcome in almost all patients. 2 In 1956, at Maryland, the first patient with metastatic choriocarcinoma was cured by methotrexate. 3 The incidence of GTD in Japan and Mexico were 2/1000 and 2.5/1000 pregnancies respectively are three times higher than in Europe or North America (0.6 -1.1/1000 pregnancies). 4, 5 The malignant potential of GTD is also higher in South Asia (10-15%) compared to western countries (2-4%).
6 It is undetermined whether such differences are attributable to genetic characteristics or to shared cultural factors. 7 The primary treatment of molar pregnancy is suction curettage, while that of choriocarcinoma is chemotherapy. Surgery is required in some patients. 8 This study tried to explore the epidemiology, management and outcome of patients with GTD in Nepal. The case records of all the gestational trophoblastic diseases during the study period were analyzed regarding their identification, illness history, clinical examination, investigations, treatment and follow-up. The main outcomes were measured in terms of age, ethnicity, duration, parity, antecedent pregnancy, histopathology, investigations, treatment, follow-up and mortality associated with this disease. All the patients having trophoblastic disease with elevated ß-hCG, radiological or hispathological evidence of the disease were included in the study. Choriocarcinoma was diagnosed on the basis of histopathology or clinical presentation along with raised level of serum ß-hCG and metastatic lesions detected by radiological examination. Statistical analysis was done using descriptive statistics: mean, range and standard deviation.
RESultS
A total of 45 cases of gestational trophoblastic diseases (GTD) from 26 districts of Nepal received during the study period. There were 17 cases (37.8%) of hydatidiform mole, six of invasive mole (13.3%), four of persistent gestational trophoblastic tumour (8.9%) and 22 patients (48.8%) of choriocarcinoma ( Table 1) . The age of the patients ranged from 16 to 50 with a mean age of 29.1 years (SD 9.4 years). The highest percentage of GTD, 51.2% (n=23) was observed in 21 -30 years and choriocarcinoma was more common (56.5%) in this age group. Magar women constituted 24.4% (n=11) of the GTD with higher percentage (54.4 %, 6/11) of malignant progression as well. Nine-teen (43%) belonged to TibetoBurmese ethnic group and 15 (33%) to Indo-Aryan ethnic group. Malignant sequelae in Tibeto-Burmese and IndoAryans were 52.6 % and 46.5% respectively.
The gestational period at presentation in 32 (71%) cases was between two to five months, in 12 (26.6%) cases it was less than two months and only in one (2.2%) case it was more than five months (Table 2) . In seven cases (15.5%), molar pregnancy had occurred in the first conception; another seven cases (15.5%) had previous molar pregnancy and 16 (35.5%) cases of GTD had occurred following abortion (Table 3) . There were three (6.6%) mortalities and remaining 37 (82.2%) of the cases were in remission and follow-up (Table  4) . 
dISCuSSIoN
This study revealed more cases of GTD among TibetoBurmese ethnic group with higher incidence of malignant sequelae as well which is similar to observation made in Hawaii study where higher incidence of GTD and metastatic disease was observed among East Asian countries (Japan, Philippines). 9 The highest frequency of GTD observed among 21 -30 years in the study was reported as significantly lower incidence in the other study. 9 However, mean age is consistent with other studies.
With regards to etiological factors, nulliparity was associated with molar pregnancies in several studies. 8, 10 But, in present study less percentage of women had GTD in the first pregnancy. Previous history of hydatidiform mole is another well-established risk factor.
11 Seven (15.5%) of cases in our study had molar pregnancy in the past among which three were found to have metastatic disease. In 50 %, choriocarcinoma is preceded by hydatidiform mole; in 25 % it follows abortion or ectopic pregnancy and in remaining 25%, delivery of a normal fetus.
12 Similar risk factors were observed for choriocarcinoma.
Experience from England and the United States reveals that complete mole is being diagnosed earlier in gestational age. 4 A study done in Saudi Arabia showed that 50% of the patients are diagnosed during their first trimester and present infrequently with the classical signs and symptoms.
13 Majority (71%) of GTD in our study presented with 2-5 months of amenorrhea which is consistent with classical description but is not consistent with recent studies from US, England and Saudi Arabia. of simultaneous evacuation and sterilization. Additionally, hysterectomy has shown to reduce the risk of malignant sequelae to approximately 3.5% from 20% anticipated for patients treated with suction curettage. 8 Nine (20%) of our patients, with family complete, underwent hysterectomy mainly for invasive mole for the advantage of sterilization, reducing morbidity and also reducing malignant squeal.
Cure rates of 90-100% have been reported in patients with non-metastatic and low-risk metastatic disease if treated appropriately. [14] [15] [16] In cases having low risk score, single agent chemotherapy with methotrexate resulted 86.6% complete remission and in cases having metastatic disease and high risk score, EMA-CO resulted in 73.7% complete remission. Overall cure rate achieved in our study is slightly lower than that of other studies.
CoNCluSIoNS
Gestational trophoblastic disease was more prevalent among young women of Tibeto-Burmese ethnicity with higher rate of progression into malignancy. Early diagnosis of disease and proper management strongly influenced the outcome of GTD and it is potentially curable even in disseminated state. The frequency of trophoblastic disease could not be obtained as our hospital is the national cancer hospital without obstetrical services. Thus, a larger multicentre study involving obstetrical department is required.
